Boothbay Fund Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1334 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1421 |
|
|
2024
Q1 | – | Sell |
-141,347
| Closed | -$397K | – | 1410 |
|
|
2023
Q4 | $397K | Buy |
141,347
+21,585
| +18% | +$60.7K | 0.01% | 932 |
|
|
2023
Q3 | $344K | Buy |
119,762
+10,469
| +10% | +$30K | 0.01% | 1020 |
|
|
2023
Q2 | $552K | Buy |
+109,293
| New | +$552K | 0.01% | 871 |
|
|
2022
Q2 | – | Sell |
-14,931
| Closed | -$41K | – | 1977 |
|
|
2022
Q1 | $41K | Hold |
14,931
| – | – | ﹤0.01% | 1809 |
|
|
2021
Q4 | $80K | Hold |
14,931
| – | – | ﹤0.01% | 1572 |
|
|
2021
Q3 | $126K | Sell |
14,931
-6,353
| -30% | -$53.6K | ﹤0.01% | 1508 |
|
|
2021
Q2 | $259K | Buy |
21,284
+1,835
| +9% | +$22.3K | 0.01% | 1213 |
|
|
2021
Q1 | $472K | Sell |
19,449
-17,312
| -47% | -$420K | 0.02% | 791 |
|
|
2020
Q4 | $1.18M | Sell |
36,761
-6,113
| -14% | -$196K | 0.04% | 363 |
|
|
2020
Q3 | $1.3M | Buy |
42,874
+20,846
| +95% | +$630K | 0.08% | 294 |
|
|
2020
Q2 | $929K | Buy |
+22,028
| New | +$929K | 0.06% | 343 |
|